RNAC logo

Cartesian Therapeutics (RNAC) Non Current Assets

Annual Non Current Assets

$214.32 M
+$196.57 M+1107.58%

31 December 2023

RNAC Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$226.18 M
+$3.22 M+1.45%

01 September 2024

RNAC Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RNAC Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1107.6%+1299.2%
3 y3 years+1420.9%+1369.3%
5 y5 years+8807.8%+6503.8%

RNAC Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+1420.9%at high+1369.3%
5 y5 yearsat high+8807.8%at high+7693.9%
alltimeall timeat high+8807.8%at high+9863.9%

Cartesian Therapeutics Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$226.18 M(+1.4%)
June 2024
-
$222.96 M(+4.1%)
Mar 2024
-
$214.10 M(-0.1%)
Dec 2023
$90.73 M(-38.8%)
$214.32 M(+1225.8%)
Sept 2023
-
$16.16 M(-3.7%)
June 2023
-
$16.78 M(-3.0%)
Mar 2023
-
$17.30 M(-2.5%)
Dec 2022
$148.14 M(+2.6%)
-
Dec 2022
-
$17.75 M(-4.5%)
Sept 2022
-
$18.59 M(+20.0%)
June 2022
-
$15.50 M(-1.2%)
Mar 2022
-
$15.69 M(+1.6%)
Dec 2021
$144.44 M(-4.6%)
$15.44 M(+0.3%)
Sept 2021
-
$15.39 M(+12.3%)
June 2021
-
$13.71 M(+0.7%)
Mar 2021
-
$13.62 M(-3.3%)
Dec 2020
$151.34 M
$14.09 M(-2.8%)
Sept 2020
-
$14.49 M(+2.4%)
June 2020
-
$14.15 M(-1.4%)
DateAnnualQuarterly
Mar 2020
-
$14.36 M(+394.8%)
Dec 2019
$96.67 M(+129.7%)
$2.90 M(-15.3%)
Sept 2019
-
$3.42 M(+37.1%)
June 2019
-
$2.50 M(-15.4%)
Mar 2019
-
$2.95 M(+22.8%)
Dec 2018
$42.08 M(-57.4%)
$2.41 M(-49.4%)
Sept 2018
-
$4.75 M(+3.3%)
June 2018
-
$4.60 M(-7.1%)
Mar 2018
-
$4.95 M(+104.7%)
Dec 2017
$98.68 M(+13.7%)
$2.42 M(+2.1%)
Sept 2017
-
$2.37 M(-3.1%)
June 2017
-
$2.45 M(+3.2%)
Mar 2017
-
$2.37 M(-4.6%)
Dec 2016
$86.82 M(+123.1%)
$2.48 M(+4.3%)
Sept 2016
-
$2.38 M(+4.9%)
June 2016
-
$2.27 M(-53.1%)
Mar 2016
-
$4.84 M(+23.7%)
Dec 2015
$38.91 M(+103.6%)
$3.91 M
Dec 2014
$19.11 M
-

FAQ

  • What is Cartesian Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Cartesian Therapeutics?
  • What is Cartesian Therapeutics annual non current assets year-on-year change?
  • What is Cartesian Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Cartesian Therapeutics?
  • What is Cartesian Therapeutics quarterly non current assets year-on-year change?

What is Cartesian Therapeutics annual long term assets?

The current annual non current assets of RNAC is $214.32 M

What is the all time high annual non current assets for Cartesian Therapeutics?

Cartesian Therapeutics all-time high annual long term assets is $214.32 M

What is Cartesian Therapeutics annual non current assets year-on-year change?

Over the past year, RNAC annual long term assets has changed by +$196.57 M (+1107.58%)

What is Cartesian Therapeutics quarterly long term assets?

The current quarterly non current assets of RNAC is $226.18 M

What is the all time high quarterly non current assets for Cartesian Therapeutics?

Cartesian Therapeutics all-time high quarterly long term assets is $226.18 M

What is Cartesian Therapeutics quarterly non current assets year-on-year change?

Over the past year, RNAC quarterly long term assets has changed by +$210.01 M (+1299.20%)